Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


UTD THERAPEUTIC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Service sales--------------------
License fees--------------------
Net product sales1,483.301,448.801,627.801,725.301,598.801,460.601,279.501,106.94906.12741.09
Service sales to affiliates--------------------
Other revenues----------5.209.0010.049.952.09
Grant revenue--------------------
Total Revenues1,483.301,448.801,627.801,725.301,598.801,465.801,288.501,116.98916.08743.18
Cost of product sales108.10117.60198.70105.7072.7069.00125.90131.13119.3088.90
Cost of service sales--------------------
Research and development357.701,182.60357.90264.60147.60245.10242.50299.35173.39180.02
Sales and marketing--------------------
Selling, general and administrative423.90336.20265.80330.10316.80452.70381.30394.01201.75156.48
Settlement of loss contingency------(210.00)0.00----------
Total Operating Expenses889.701,636.40822.40910.40--766.80749.70--494.43425.40
Operating Income (Loss)593.60(187.60)805.40814.901,061.70699.00538.80292.50421.65317.78
Interest expense23.5044.2013.909.003.904.7017.6018.0616.6421.37
Write-down of investment--------------------
Impairment of cost method investment------49.600.000.00--------
Impairments of investments in privately-held companies9.100.0053.50--------------
Gain on sale of intangible asset----------350.00--0.00----
Gain (Loss) on marketable investments--------------------
Equity loss in affiliate--------------------
Interest income28.6044.2028.6010.903.50--------3.45
Other income (expense)49.3022.60(7.70)2.30(1.10)0.104.004.4635.66(0.75)
Total other (expense) income, net45.3022.60(46.50)(45.40)537.10345.40(13.60)824.4919.03(18.67)
Income before income tax638.90(165.00)758.90769.501,060.201,044.40525.20278.90440.67299.12
Current- Foreign--------------2.160.660.54
Current: Federal----------351.20166.40120.0383.9154.13
Current: State----------37.0021.4020.1013.958.95
Deferred: Federal----------(2.70)(3.10)(37.71)37.2611.23
Deferred: State----------7.300.40(9.06)(0.42)(2.43)
Deferred: Foreign------------------0.64
Income tax provision (benefit)124.10(60.50)169.70351.60346.50392.80185.10104.34136.2381.87
Other Non-Current: Federal------------------7.61
Other Non-Current: State------------------1.62
Other non-current: Foreign--------------(1.06)0.18(0.42)
Income from Continuing Operations------------------217.24
Income from Discontinued Operations------------------0.01
Gain on disposal of discontinued operations, net of tax------------------0.62
Net Income (loss) Available to Common Shareholders514.80(104.50)589.20417.90713.70651.60340.10174.56304.44217.87
Income from continuing operations -EPS (Basic)------------------3.80
Discontinued operations EPS (Basic)------------------0.01
Net Earnings Per Share (Basic)11.65(2.39)13.549.5016.2914.177.063.495.843.81
Income from continuing operations -EPS (Diluted------------------3.66
Discontinued operations EPS (Diluted)------------------0.01
Net Earnings Per Share (Diluted)11.54(2.39)13.399.3115.2512.726.283.285.713.67
Weighted Average Shares Outstanding (Basic)44.2043.8043.5044.0043.8046.0048.2050.0852.0957.16
Weighted Average Shares Outstanding (Diluted)44.6043.8044.0044.9046.8051.2054.2053.2353.2859.40